CF Foundation Therapeutics Development Network: Ledger

Stories naming CF Foundation Therapeutics Development Network. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
CF Foundation Therapeutics Development Network is not recorded as having acquired anything.

2 deals

MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis

The MRCF Biomedical Translation Fund has launched Respirion Pharmaceuticals, a Perth biotech developing an inhaled antibiotic for cystic fibrosis, committing up to A$20 million, with up to US$3 million from the CF Foundation.

Brandon Capital portfolio Fri 15 Mar 2019 Respirion Brandon Capital Partners CF Foundation Therapeutics Development Network Department of Health Medical Research Commercialisation Fund (MRCF)Perth Children's Hospital Telethon Kids Institute MRCF-BTF US Cystic Fibrosis Foundation Dr Barry Clements Dr Kath Giles

Also Brandon BioCatalyst portfolio·@AuManufacturing

CF Foundation Therapeutics Development Network

Funding history

Investors

What CF Foundation Therapeutics Development Network bought

People

Coverage

MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis